☰

Sherrye T. Glaser, Ph.D. - Publications

Affiliations: 
2003 Stony Brook University, Stony Brook, NY, United States 
Area:
Biochemistry, Cell Biology, Neuroscience Biology
Tree Info Grants Similar researchers PubMed Report error

20 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Glaser ST, Jayanetti K, Oubraim S, Hillowe A, Frank E, Jong J, Wang L, Wang H, Ojima I, Haj-Dahmane S, Kaczocha M. Fatty acid binding proteins are novel modulators of synaptic epoxyeicosatrienoic acid signaling in the brain. Scientific Reports. 13: 15234. PMID 37709856 DOI: 10.1038/s41598-023-42504-4  0.689
2022 Fauzan M, Oubraim S, Yu M, Glaser ST, Kaczocha M, Haj-Dahmane S. Fatty Acid-Binding Protein 5 Modulates Brain Endocannabinoid Tone and Retrograde Signaling in the Striatum. Frontiers in Cellular Neuroscience. 16: 936939. PMID 35875351 DOI: 10.3389/fncel.2022.936939  0.65
2016 Hu K, Sonti S, Glaser ST, Duclos RI, Gatley SJ. Brain uptake and metabolism of the endocannabinoid anandamide labeled in either the arachidonoyl or ethanolamine moiety. Nuclear Medicine and Biology. 45: 43-50. PMID 27889577 DOI: 10.1016/J.Nucmedbio.2016.11.001  0.381
2015 Kaczocha M, Glaser ST, Maher T, Clavin B, Hamilton J, O'Rourke J, Rebecchi M, Puopolo M, Owada Y, Thanos PK. Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms. Molecular Pain. 11: 52. PMID 26311517 DOI: 10.1186/S12990-015-0056-8  0.727
2015 Kaczocha M, Glaser ST, Maher T, Clavin B, Hamilton J, O'Rourke J, Rebecchi M, Puopolo M, Owada Y, Thanos PK. Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms Molecular Pain. 11. DOI: 10.1186/s12990-015-0056-8  0.657
2014 Kaczocha M, Rebecchi MJ, Ralph BP, Teng YH, Berger WT, Galbavy W, Elmes MW, Glaser ST, Wang L, Rizzo RC, Deutsch DG, Ojima I. Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia. Plos One. 9: e94200. PMID 24705380 DOI: 10.1371/Journal.Pone.0094200  0.767
2013 Leung K, Elmes MW, Glaser ST, Deutsch DG, Kaczocha M. Role of FAAH-like anandamide transporter in anandamide inactivation. Plos One. 8: e79355. PMID 24223930 DOI: 10.1371/Journal.Pone.0079355  0.769
2012 Vaitheesvaran B, Yang L, Hartil K, Glaser S, Yazulla S, Bruce JE, Kurland IJ. Peripheral effects of FAAH deficiency on fuel and energy homeostasis: role of dysregulated lysine acetylation. Plos One. 7: e33717. PMID 22442717 DOI: 10.1371/Journal.Pone.0033717  0.338
2012 Kaczocha M, Vivieca S, Sun J, Glaser ST, Deutsch DG. Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors. The Journal of Biological Chemistry. 287: 3415-24. PMID 22170058 DOI: 10.1074/Jbc.M111.304907  0.777
2011 Duclos RI, Johnston M, Vadivel SK, Makriyannis A, Glaser ST, Gatley SJ. A methodology for radiolabeling of the endocannabinoid 2-arachidonoylglycerol (2-AG). The Journal of Organic Chemistry. 76: 2049-55. PMID 21370840 DOI: 10.1021/Jo102277Q  0.302
2010 Glaser ST, Kaczocha M. Cyclooxygenase-2 mediates anandamide metabolism in the mouse brain. The Journal of Pharmacology and Experimental Therapeutics. 335: 380-8. PMID 20702753 DOI: 10.1124/Jpet.110.168831  0.676
2010 Kaczocha M, Glaser ST, Chae J, Brown DA, Deutsch DG. Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2. The Journal of Biological Chemistry. 285: 2796-806. PMID 19926788 DOI: 10.1074/Jbc.M109.058461  0.736
2009 Glaser ST, Kaczocha M. Temporal changes in mouse brain fatty acid amide hydrolase activity Neuroscience. 163: 594-600. PMID 19555737 DOI: 10.1016/J.Neuroscience.2009.06.043  0.668
2009 Kaczocha M, Glaser ST, Deutsch DG. Identification of intracellular carriers for the endocannabinoid anandamide. Proceedings of the National Academy of Sciences of the United States of America. 106: 6375-80. PMID 19307565 DOI: 10.1073/Pnas.0901515106  0.782
2006 Kaczocha M, Hermann A, Glaser ST, Bojesen IN, Deutsch DG. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase. The Journal of Biological Chemistry. 281: 9066-75. PMID 16461355 DOI: 10.1074/Jbc.M509721200  0.772
2006 Glaser ST, Gatley SJ, Gifford AN. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain. The Journal of Pharmacology and Experimental Therapeutics. 316: 1088-97. PMID 16278311 DOI: 10.1124/Jpet.105.094748  0.429
2005 Glaser ST, Deutsch DG, Studholme KM, Zimov S, Yazulla S. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide. Visual Neuroscience. 22: 693-705. PMID 16469181 DOI: 10.1017/S0952523805226020  0.663
2005 Glaser ST, Kaczocha M, Deutsch DG. Anandamide transport: a critical review. Life Sciences. 77: 1584-604. PMID 15979096 DOI: 10.1016/J.Lfs.2005.05.007  0.783
2003 Glaser ST, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, Deutsch DG. Evidence against the presence of an anandamide transporter. Proceedings of the National Academy of Sciences of the United States of America. 100: 4269-74. PMID 12655057 DOI: 10.1073/Pnas.0730816100  0.775
2001 Deutsch DG, Glaser ST, Howell JM, Kunz JS, Puffenbarger RA, Hillard CJ, Abumrad N. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. The Journal of Biological Chemistry. 276: 6967-73. PMID 11118429 DOI: 10.1074/Jbc.M003161200  0.711
Show low-probability matches.